Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation

Journal of Clinical Investigation

Volumn 96, Issue 6, 1995, Pages 2947-2954

  Niimura, Fumio ^a   Labosky, Patricia A ^a   Kakuchi, Junji ^a   Okubo, Soichiro ^a   Yoshida, Hiroaki ^a   Oikawa, Tsuyoshi ^a   Ichiki, Toshihiro ^a   Naftilan, Allen J ^a   Fogo, Agnes ^a   Inagami, Tadashi ^a   Hogan, Brigid L M ^a   Ihikawa, Iekuni ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

angiotensinogen; hypotension; nephrosclerosis; platelet derived growth factor; transforming growth factor

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; GROWTH FACTOR RECEPTOR; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CONTROLLED STUDY; GENE MUTATION; GENE TARGETING; GROWTH REGULATION; HISTOPATHOLOGY; KIDNEY DEVELOPMENT; MOUSE; NEPHROSCLEROSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0028821842     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118366     Document Type: Article

References (39)

1. Kakuchi, J., T. Ichiki, S. Kiyama, B. L. M. Hogan, A. Fogo, T. Inagami, and I. Ichikawa. 1995. Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int. 47:140-147.
2. Richoux, J. P., S. Amsaguine, G. Grignon, J. Bouhnik, J. Menard, and P. Corvol. 1987. Earliest renin containing cell differentiation during ontogenesis in the rat. Histochemistry. 88:41-46.
3. Gomez, R. A., C. Pupilli, and A. D. Everett. 1991. Molecular and cellular aspects of renin during kidney ontogeny. Pediatr. Nephrol. 5:80-87.
4. Wallace, K. B., M. D. Bailie, and J. B. Hook. 1979. Development of angiotensin-converting enzyme in fetal rat lungs. Am. J. Physiol. 236:R57-R60.
5. Mounier, F., N. Hinglais, M. Sich, F. Gros, M. Lacoste, Y. Deris, F. Alhenk-Gelas, and M. C. Gubler. 1987. Ontogenesis of angiotensin-I converting enzyme in human kidney. Kidney Int. 32:684-690.
6. Fogo, A., Y. Yoshida, A. Yared, and I. Ichikawa. 1990. Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys. Kidney Int. 38:1068-1074.
7. Tufro-McReddie, A., D. W. Johns, K. M. Geary, H. Dagli, A. D. Everett, R. L. Chevalier, R. M. Carey, and R. A. Gomez. 1994. Angiotensin II type 1 receptor: role in renal growth and gene expression during normal development. Am. J. Physiol. 266:F911-F918.
8. Friberg, P., B. Sundelin, S.-O. Bohman, A. Bobik, H. Nilsson, A. Wickman, H. Gustafsson, J. Petersen, and M. A. Adams. 1994. Renin-angiotensin system in neonatal rats: Induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int. 45:485-492.
9. Lewis, E. J., L. G. Hunsicker, R. P. Bain, and R. D. Rohde, for The Collaborative Study Group. 1993. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329:1456-1462.
10. Cattran, D. C., C. Greenwood, and S. Ritchie. 1994. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am. J. Kidney Dis. 23:247-254.
11. Baker, K. M., M. I. Chernin, S. K. Wixson, and J. F. Aceto. 1990. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am. J. Physiol. 259:H324-H332.
12. Clozel, J. P., and F. Hefti. 1988. Cilazapril prevents the development of cardiac hypertrophy and the decrease of coronary vascular reserve in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 11:568-572.
13. Anderson, S., H. G. Rennke, and B. M. Brenner. 1986. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J. Clin. Invest. 77:1993-2000.
14. Kakinuma, Y., T. Kawamura, T. Bills, T. Yoshioka, and I. Ichikawa, and A. Fogo. 1992. Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int. 42:46-55.
15. Zatz, R., R. Dunn, T. W. Meyer, S. Anderson, H. G. Rennke, and B. M. Brenner. 1986. Prevention of diabetic glomerulonephropathy by pharmacological amelioration of glomerular capillary hypertension. J. Clin. Invest. 77:1925-1930.
16. Anderson, S., T. W. Meyer, H. G. Rennke, and B. M. Brenner. 1985. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 76:612-619.
17. Lafayette, R. A., G. Mayer, S. K. Park, and T. W. Meyer. 1992. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 90:766-771.
18. Kaneto, H., J. Morrissey, R. McCracken, A. Reyes, and S. Klahr. 1994. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed kidney. Kidney Int. 45:1637-1647.
19. Cooper, M. E., J. Rumble, R. Komers, D. He-Cheng, K. Jandeleit, and C. Scheung-To. 1994. Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition. Diabetes. 43:1221-1228.
20. Kim, H. S., J. H. Krege, K. D. Kluckman, J. R. Hagaman, J. B. Hodgin, C. F. Best, J. C. Jennette, T. M. Coffman, N. Maeda, and O. Smithies. 1995. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. USA. 92:2735-2739.
21. Tanimoto, K., F. Sugiyama, Y. Goto, J. Ishida, K. Yagami, A. Fukamizu, and K. Murakami. 1994. Angiotensinogen-deficient mice with hypotension. J. Biol. Chem. 269:31334-31337.
22. Hooper, M., K. Hardy, A. Handyside, S. Hunter, and M. Monk. 1987. HPRT-deficient (Lesh-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature (Lond.). 326:292-295.
23. Remirez-Solis, R., A. C. Davis, and A. Bradley. 1993. Gene targeting in embryonic stem cells. Methods Enzymol. 225:855-878.
24. Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the mouse embryo. 2nd Edition. Cold Spring Harbor Labolatory Press, Cold Spring Harbor, NY 255 pp.
25. Clouston, W. M., B. A. Evans, J. Haralambidis, and R. I. Richards. 1988. Molecular cloning of the mouse angiotensinogen gene. Genomics. 2:240-248.
26. Misono, K. S., L. A. Holladay, K. Murakami, K. Kuromizu, and T. Inagami. 1982. Rapid and large-scale purification and characterization of renin from mouse submaxillary gland. Arch. Biochem. Biophys. 217:574-581.
27. Mercola, M., C. Y. Wang, J. Kelly, C. Brownlee, L. Jackson-Grusby, C. Stiles, and D. Bowen-Pope. 1990. Selective expression of PDGF-A and its receptor during early mouse embryogenesis. Dev. Biol. 138:114-122.
28. Tanaka, R., K. Sugiura, A. Tatematsu, and A. Fogo. 1995. Internephron heterogeneity of growth factors and sclerosis: modulation of platelet-derived growth factor by angiotensin II. Kidney Int. 47:131-139.
29. Pelton, R. W., M. E. Dickinson, H. L. Moses, and B. L. M. Hogan. 1990. In situ hybridization analysis of TGFβ3 RNA expression during mouse development: comparative studies with TGFβ1 and β2. Development (Camb.). 110:609-620.
30. Kiyama, S., T. Yoshioka, I. M. Burr, V. Kon, A. Fogo, and I. Ichikawa. 1995. Strategic locus for the activation of the superoxide dismutase gene in the nephron. Kidney Int. 47:536-546.
31. Schwartz, S. M., M. K. Majesky, and R. J. Dilley. 1990. Vascular remodeling in hypertension and atherosclerosis. In Hypertension: Pathophysiology, Diagnosis, and Management. G. H. Laragh and B. M. Brenner, editors. Raven Press, Ltd., New York. 521-539.
32. Gomez, R. A., R. L. Chevalier, A. D. Everett, J. P. Elwood, M. J. Peach, and K. R. Lynch. 1990. Recruitment of renin gene-expressing cells in adult rat kidneys. Am. J. Physiol. 259:F660-F665.
33. Johns, D. W., M. J. Peach, R. A. Gomez, T. Inagami, and R. M. Carey. 1990. Angiotensin II regulates renin gene expression. Am. J. Physiol. 259:F882-F887.
34. Langille, B. L., and F. O'Donnell. 1986. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science (Wash. DC). 231:405-407.
35. DiCorleto, P. E., and D. F. Bowen-Pope. 1983. Cultured endothelial cells produce a platelet-derived growth factor-like protein. Proc. Natl. Acad. Sci. USA. 80:1919-1923.
36. Naftilan, A. J., R. E. Pratt, and V. J. Dzau. 1989. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1419-1424.
37. Gibbons, G. H., R. E. Pratt, and V. J. Dzau. 1992. Vascular smooth muscle cell hypertrophy vs hyperplasia. Autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J. Clin. Invest. 90:456-461.
38. Kagami, S., W. A. Border, D. E. Miller, and N. A. Noble. 1994. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J. Clin. Invest. 93:2431-2437.
39. Peten, E. P., L. J. Striker, A. Fogo, I. Ichikawa, A. Patel, and G. E. Striker. 1994. The molecular basis of increased glomerulosclerosis after blockade of the renin angiotensin system in growth hormone transgenic mice. Mol. Med. 1:104-115.